Sage Rhino Capital LLC Eli Lilly & CO Transaction History

Sage Rhino Capital LLC

$439 Million
Q3 2024

A detailed history of Sage Rhino Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Sage Rhino Capital LLC holds 2,150 shares of LLY stock, worth $1.67 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

2,150

Previous 2,143 0.33%

Holding current value

$1.67 Million

Previous $1.94 Million 1.86%

% of portfolio

0.43%

Previous 0.48%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$772.14 - $960.02 $5,404 - $6,720	7 Added 0.33%	2,150 $1.9 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $17,396 - $21,816	24 Added 1.13%	2,143 $1.94 Million
Q1 2024 Apr 26, 2024	BUY	$592.2 - $792.28 $9,475 - $12,676	16 Added 0.76%	2,119 $1.65 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $15,755 - $18,573	-30 Reduced 1.41%	2,103 $1.23 Million
Q2 2023 Jul 31, 2023	SELL	$350.74 - $468.98 $6,664 - $8,910	-19 Reduced 0.88%	2,133 $1 Million
Q1 2023 Apr 20, 2023	BUY	$310.63 - $364.82 $11,803 - $13,863	38 Added 1.8%	2,152 $739,000
Q4 2022 Jan 31, 2023	SELL	$321.55 - $374.67 $6,109 - $7,118	-19 Reduced 0.89%	2,114 $773,000
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $5,040 - $5,743	-17 Reduced 0.79%	2,133 $690,000
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $2,787 - $3,272	10 Added 0.47%	2,150 $697,000
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $469 - $583	2 Added 0.09%	2,140 $613,000
Q4 2021 Feb 04, 2022	SELL	$224.85 - $279.04 $2,698 - $3,348	-12 Reduced 0.56%	2,138 $591,000
Q3 2021 Oct 18, 2021	BUY	$221.6 - $272.71 $13,960 - $17,180	63 Added 3.02%	2,150 $497,000
Q2 2021 Jul 27, 2021	BUY	$180.55 - $233.54 $7,583 - $9,808	42 Added 2.05%	2,087 $479,000
Q1 2021 May 04, 2021	BUY	$164.32 - $212.72 $4,765 - $6,168	29 Added 1.44%	2,045 $382,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $6,001 - $7,940	46 Added 2.34%	2,016 $340,000
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $10,966 - $12,684	-75 Reduced 3.67%	1,970 $292,000
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $16,097 - $19,373	118 Added 6.12%	2,045 $336,000
Q1 2020 Apr 29, 2020	BUY	$119.05 - $147.35 $2,738 - $3,389	23 Added 1.21%	1,927 $267,000
Q4 2019 Jan 31, 2020	SELL	$106.92 - $132.43 $62,334 - $77,206	-583 Reduced 23.44%	1,904 $263,000
Q3 2019 Oct 25, 2019	SELL	$106.79 - $116.16 $8,436 - $9,176	-79 Reduced 3.08%	2,487 $278,000
Q2 2019 Aug 20, 2019	SELL	$110.79 - $129.32 $15,953 - $18,622	-144 Reduced 5.31%	2,566 $284,000
Q1 2019 Apr 18, 2019	BUY	$111.31 - $131.02 $301,650 - $355,064	2,710 New	2,710 $352,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $740B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Rhino Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Rhino Capital LLC with notifications on news.

Account

Sage Rhino Capital LLC Eli Lilly & CO Transaction History